About & Methodology
Every number on phrma.in traces to a named government source. No estimates, no projections, no surveys.
phrma.in is built on official government trade statistics — not estimates, not projections, not surveys. Every number traces to a source: India's Directorate General of Commercial Intelligence and Statistics (DGCIS), the US Census Bureau, Eurostat, HMRC, Statistics Canada, and the Reserve Bank of India.
| Source | Coverage | Used For |
|---|---|---|
| DGCIS India | FY 2014–15 to 2025–26 | India's pharma exports by destination, HS8 product detail, category mix |
| US Census Bureau | CY 2015–2025 | US imports from India — partner-side headline for US profile |
| Eurostat | CY 2015–2025 | EU member state imports from India |
| HMRC UK | CY 2015–2025 | UK imports from India |
| Statistics Canada | CY 2015–2025 | Canadian imports from India |
| RBI ODI Data | 2011–2026 | Indian pharma overseas direct investment — equity, loans, guarantees |
Where a destination country publishes its own import data (the "mirror" or "partner" statistics), we show both sides. Partner data often captures shipments that DGCIS misses, and vice versa — dual-source profiles give the most complete picture available.
Fiscal vs. calendar year: DGCIS data follows India's fiscal year (April–March), labelled as the ending year (FY 2025–26 covers April 2025 to March 2026). Partner-country data follows the calendar year. Where both appear on the same profile, the year basis is always labelled.
Product classification: Exports are classified at the 8-digit HS code level. Products are grouped into four categories: Drug Formulations, Bulk Drugs & APIs, Surgicals, and AYUSH/Herbal — following the standard pharma export taxonomy used by the Pharmaceuticals Export Promotion Council of India (Pharmexcil).
Currency: All trade values are in US dollars. DGCIS originally reports in Indian rupees; we convert using the RBI reference rate for the corresponding month. Partner-country data is reported in USD at source.
Data is updated as source agencies publish — designed for trade policy professionals, industry analysts, and export promotion bodies who need accurate, granular, and current data on India's pharmaceutical trade.